Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Washington
City of Hope Medical Center
City of Hope Medical Center
University of Miami
Thomas Jefferson University
Academic and Community Cancer Research United
Gilead Sciences
Incyte Corporation
City of Hope Medical Center
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Northwestern University
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Seagen Inc.
University of Washington
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center